BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 866797)

  • 1. Prognosis of prostatic carcinoma.
    Mellinger GT
    Recent Results Cancer Res; 1977; (60):61-72. PubMed ID: 866797
    [No Abstract]   [Full Text] [Related]  

  • 2. Orchiectomy for advanced prostatic carcinoma. A reevaluation.
    Blackard CE; Byar DP; Jordan WP
    Urology; 1973 Jun; 1(6):553-60. PubMed ID: 4588820
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
    Gleason DF; Mellinger GT
    J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554
    [No Abstract]   [Full Text] [Related]  

  • 4. A reappraisal of total prostatectomy for prostatic cancer.
    Bruce PT
    Med J Aust; 1970 May; 1(22):1103-5. PubMed ID: 5430489
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging.
    Gleason DF; Mellinger GT;
    J Urol; 2017 Feb; 197(2S):S134-S139. PubMed ID: 28012760
    [No Abstract]   [Full Text] [Related]  

  • 6. Latent carcinoma of the prostate--why the controversy?
    Correa RJ; Anderson RG; Gibbons RP; Mason JT
    J Urol; 1974 May; 111(5):644-6. PubMed ID: 4823973
    [No Abstract]   [Full Text] [Related]  

  • 7. Endocrine treatment of cancer of the prostate.
    Madsen PO; Pedersen JF; Knuth OE
    Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084
    [No Abstract]   [Full Text] [Related]  

  • 8. [Retrospective clinical evaluation of prognosis factors in stage D2 prostatic cancer treated with endocrine therapy].
    Kudo K; Nagata M; Hayashi N; Imamura H; Kimura M; Mimura H; Matsuyama K; Shishido S; Chino I
    Hinyokika Kiyo; 1991 Feb; 37(2):129-34. PubMed ID: 1710871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The appropriate uses of prostatic acid phosphatase determination in the diagnosis of adenocarcinoma of the prostate.
    Griffiths J
    Ann N Y Acad Sci; 1982; 390():100-3. PubMed ID: 6953922
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate Carcinoma-therapeutic considerations in the management of gross lymph node metastases.
    Green N; Broth E; George FW; Goldstein A; Melbye RW; Morrow J; Onofrio R; Polse S; Skaist L
    Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):891-7. PubMed ID: 115816
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoma of the prostate presenting as a mass in the neck.
    Warren MM; Furlow WL
    JAMA; 1970 Jul; 213(4):620-1. PubMed ID: 5468204
    [No Abstract]   [Full Text] [Related]  

  • 12. Lung metastases in prostatic carcinoma. Clinical significance.
    Varkarakis MJ; Winterberger AR; Gaeta J; Moore RH; Murphy GP
    Urology; 1974 Apr; 3(4):447-52. PubMed ID: 4856662
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience.
    Zincke H
    Semin Urol; 1990 Aug; 8(3):175-83. PubMed ID: 2399386
    [No Abstract]   [Full Text] [Related]  

  • 14. An unusual remission of prostatic carcinoma with pulmonary metastases.
    Stenberg CC; Bunts RC
    J Urol; 1969 Aug; 102(2):236-9. PubMed ID: 5796902
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioimmunoassay for prostatic acid phosphatase in early prostatic carcinoma.
    Samuell CT; Morgans BT; O'Donoghue EP
    Br J Urol; 1984 Apr; 56(2):208-12. PubMed ID: 6498440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A retrospective clinical study of relapsed prostatic cancer].
    Takigawa H; Kagawa S; Aga Y; Kurokawa K
    Nihon Hinyokika Gakkai Zasshi; 1987 Sep; 78(9):1545-52. PubMed ID: 3444181
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution on the clinical aspects of prostatic carcinoma].
    Sladczyk E
    Z Arztl Fortbild (Jena); 1967 Jul; 61(13):657-60. PubMed ID: 5598256
    [No Abstract]   [Full Text] [Related]  

  • 18. EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
    Robinson MR
    Prog Clin Biol Res; 1988; 260():101-10. PubMed ID: 2966402
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.
    Tsai H; Morais CL; Alshalalfa M; Tan HL; Haddad Z; Hicks J; Gupta N; Epstein JI; Netto GJ; Isaacs WB; Luo J; Mehra R; Vessella RL; Karnes RJ; Schaeffer EM; Davicioni E; De Marzo AM; Lotan TL
    Clin Cancer Res; 2015 Dec; 21(24):5619-29. PubMed ID: 26246306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.